Merck celebrates its 350th anniversary

MerckMerck, a leading science and technology company, will celebrate its 350th anniversary this year with customers, partners and employees under the motto "Past. Present. Future." In 1668, the pharmacist Friedrich Jacob Merck laid the cornerstone for what Merck is today - a vibrant, global science and technology company. "350 years, that's an incredible number, especially if you consider everything that has happened in the world of science between 1668 and today. We are proud of the many contributions Merck has made to research and development. And we will also continue to do exactly the same. In other words, we are infinitely curious about what is coming," said Stefan Oschmann, Executive Board Chairman and CEO of Merck.

A highlight of the anniversary year will be the "Curious2018 - Future Insight" conference in Darmstadt in mid-July 2018. This will be attended by more than 35 renowned international scientists - including five Nobel Prize laureates - who on three days will be presenting their work and discussing the future of science and technology. Merck is supporting this premiere event as the main sponsor. The speakers will present to an audience of around 1,000 guests from all over the world topics oriented to the main focal areas of the three Merck business sectors (Healthcare "Healthy Lives - new breakthrough therapies and diagnostics", Life Science "Life Reimagined - synthetic biology and beyond", and Performance Materials "Materials & Solutions - chemistry and beyond"). Other topics of the conference address questions regarding digitalization ("Vibrant Digital - the power of in silico") and new forms of collaboration ("Bright Future - new ways of working and collaborating").

"We are fighting cancer and other serious diseases. We are helping other companies to conduct research even more quickly and efficiently. And we are developing high-tech materials with which autonomous driving or foldable displays, for example, are becoming reality. We are doing all this in close partnership with top researchers around the globe. Therefore, we are very much looking forward to a huge celebration of research with the best of the best," said Stefan Oschmann.

Besides the five Nobel Prize-winning scientists - Joachim Frank (2017, Chemistry), Fraser Stoddart (2016, Chemistry), Bruce Beutler (2011, Medicine), Harald zur Hausen (2008, Medicine), Jean-Marie Lehn (1987, Chemistry) - further renowned representatives of the scientific and business communities, among others, will be present at "Curious2018 - Future Insight".

Another central event in Merck's anniversary year is the European ceremony on May 3, 2018 in a pavilion especially constructed for the celebrations. Around 900 guests from the worlds of politics and business are invited to this event in Darmstadt. Further regional ceremonies will take place in June in Shanghai, China and in October in Boston, USA.

In addition, as part of the European ceremony on May 3, the new Innovation Center will be officially opened. The newly designed and constructed building at the heart of Merck headquarters offers start-ups and company-internal innovation teams a five times larger area than was formerly available for working on innovation projects outside the existing business.

"It is a great joy to collaborate with young entrepreneurs. And who knows, one of the promoted business ideas might evolve some time into a company like Merck. After all, we also began as a start-up in 1668," said Stefan Oschmann.

Before Merck celebrates with external customers, partners and representatives of society, a celebration for employees will take place on April 18/19. This is planned for the around 50,000 people working at Merck worldwide and will extend over all continents for 24 hours.

"The celebration is a huge expression of our thanks to all our employees worldwide. With their work day by day, they ensure the success of our company. In Darmstadt we have many employees whose families have worked loyally for Merck over generations, which we highly esteem. Yet more and more talented people join Merck from all over the world, because they feel that Merck is a place where exciting things can be made to happen. In April, together with all of them, we will celebrate 350 years and the future," said Stefan Oschmann.

The other numerous events marking the 350th anniversary of Merck include the national "Jugend forscht" (Young Researchers) competition under the auspices of German Federal President Frank-Walter Steinmeier, which will take place in Darmstadt from May 24 to 27. The "Federal President's Award for Outstanding Work" is among the prestigious prizes awarded at the German national finals.

A highlight towards the end of the anniversary celebrations in autumn will be an Open Day on September 22, 2018 at global headquarters in Darmstadt. Interested visitors will then have the opportunity to take a look behind the scenes of the science and technology company Merck.

About Merck
Merck is a leading science and technology company in healthcare, life science and performance materials. Around 50,000 employees work to further develop technologies that improve and enhance life – from biopharmaceutical therapies to treat cancer or multiple sclerosis, cutting-edge systems for scientific research and production, to liquid crystals for smartphones and LCD televisions. In 2016, Merck generated sales of € 15.0 billion in 66 countries.

Founded in 1668, Merck is the world's oldest pharmaceutical and chemical company. The founding family remains the majority owner of the publicly listed corporate group. Merck holds the global rights to the Merck name and brand. The only exceptions are the United States and Canada, where the company operates as EMD Serono, MilliporeSigma and EMD Performance Materials.

Most Popular Now

Amgen and Allergan's MVASI™ (bevacizumab-awwb) and…

Amgen (NASDAQ:AMGN) and Allergan plc (NYSE:AGN) announced that MVASI™ (bevacizumab-awwb), a biosimilar to Avastin® (bevacizumab), and KANJINTITM (trastuzumab-anns), a bio...

Compound found in red wine opens door for new trea…

Like to unwind with a glass of red wine after a stressful day? Don't give alcohol all the credit. New research has revealed that the plant compound resveratrol, which is ...

HIV vaccine nears clinical trial following new fin…

A promising vaccine that clears an HIV-like virus from monkeys is closer to human testing after a new, weakened version of the vaccine has been shown to provide similar p...

Mylan and Upjohn, a division of Pfizer, to combine…

HERTFORDSHIRE, England & PITTSBURGH & Mylan N.V. (Nasdaq: MYL) and Pfizer Inc. (NYSE: PFE) today announced a definitive agreement to combine Mylan with Upjohn, Pfizer's o...

Leading oncologists and nutritionists pinpoint are…

An international collaborative led by Ludwig Cancer Research and Cancer Research UK has identified key areas that are central to uncovering the complex relationship betwe...

Closing the door: breaking new ground related to a…

In order to sustain fast growth, cancer cells need to take up nutrients at a faster rate than healthy cells. The human glutamine transporter ASCT2 allows the amino acid g...

FDA approves first generics of Lyrica

On July 19, the U.S. Food and Drug Administration approved multiple applications for first generics of Lyrica (pregabalin) for the management of neuropathic pain associat...

Roche and Spark Therapeutics, Inc. announce extens…

Roche (SIX: RO, ROG; OTCQX: RHHBY) and Spark Therapeutics, Inc. (NASDAQ: ONCE) ("Spark") announced that Roche has extended the offering period of its previously announced...

FDA approves first treatment for severe hypoglycem…

The U.S. Food and Drug Administration today approved Baqsimi nasal powder, the first glucagon therapy approved for the emergency treatment of severe hypoglycemia that c...

Rye is healthy, thanks to an interplay of microbes

Eating rye comes with a variety of health benefits. A new study from the University of Eastern Finland now shows that both lactic acid bacteria and gut bacteria contribut...

GSK completes transaction with Pfizer to form new …

The Joint Venture brings together two highly complementary portfolios of trusted consumer health brands, including GSK's Sensodyne, Voltaren and Panadol and Pfizer's Advi...

Eating more plant-based foods may be linked to bet…

Eating mostly plant-based foods and fewer animal-based foods may be linked to better heart health and a lower risk of dying from a heart attack, stroke or other cardiovas...